Dr. Rigotti is a Professor of Medicine at Harvard Medical School and founding director of Massachusetts General Hospital’s Tobacco Research and Treatment Center. A board-certified general internist, Dr. Rigotti is internationally known for her research to reduce the health burden of tobacco use by evaluating tobacco cessation treatments and promoting their adoption in health care settings, both inpatient and outpatient. Dr. Rigotti was a member of the National Academies of Science, Engineering, and Medicine panel that produced the landmark 2018 report, Public Health Consequences of E-Cigarettes. Her current work includes addressing the role of e-cigarettes for tobacco smoking cessation and harm reduction. Dr. Rigotti has authored over 350 publications and served as President of the Society for Research in Nicotine and Tobacco and as President of the Society of General Internal Medicine, which in 2015 awarded her its highest research award, the John Eisenberg National Award for Career Achievement in Research. She is a graduate of Stanford University and Harvard Medical School.
- Examine the public health risks and benefits of e-cigarette use
- Analyze the recent clinical trial evidence about the efficacy of e-cigarettes for smoking cessation
- Interpret the evidence about the potential risks of e-cigarettes for smoking cessation
- Create an evidence-based plan for discussing e-cigarettes with patients/clients who smoke cigarettes.
CME/CE credit is no longer available for the recorded version of this activity. The accreditation has expired for this course.
Certificates of Attendance
Click here to generate a certificate of attendance for participating on this webinar.